低强度CT筛查可降低肺癌死亡率

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

晚期非小细胞肺癌的精确诊断和治疗

Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer

病例21-2011：一位患ALK阳性肺腺癌的31岁男性

Case 21-2011: A 31-Year-Old Man with ALK-Positive Adenocarcinoma of the Lung

病例31-2011：一位患寡转移肺癌的55岁男性

Case 31-2011: A 55-Year-Old Man with Oligometastatic Lung Cancer

派姆单抗与化疗治疗PD-L1阳性非小细胞肺癌的比较研究

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

纳武单抗和多西他赛治疗晚期鳞状细胞非小细胞肺癌的比较研究

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

纳武单抗一线治疗Ⅳ期或复发性非小细胞肺癌

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

克唑替尼一线治疗与化疗在ALK阳性肺癌中的疗效比较

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Pembrolizumab治疗非小细胞肺癌的研究

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

克唑替尼在ROS1重排非小细胞肺癌中的应用

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

色瑞替尼治疗ALK重排非小细胞肺癌的临床研究

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer

奥希替尼或铂类-培美曲塞治疗EGFR T790M阳性肺癌的研究

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

对艾乐替尼和克唑替尼用于未经治疗的ALK阳性非小细胞肺癌的比较研究

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

追踪非小细胞肺癌的进化

Tracking the Evolution of Non-Small-Cell Lung Cancer